Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Adams

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Archives of Otolaryngology--Head & Neck Surgery|March 1, 1997
Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neckJ D McCaffery, M Gapany, R A Faust, et al.
The Journal of Infectious Diseases|August 19, 2000
Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-alpha: potential cause for mucoid otitis mediaJ Lin, A Haruta, H Kawano, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 17, 1998
Histopathology of human temporal bone after cis-platinum, radiation, or bothD L Hoistad, F G Ondrey, C Mutlu, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 1, 1994
Tobacco smoke and otitis media in the chinchilla modelP J Antonelli, K A Daly, S K Juhn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393A A Forastiere, T Leong, E Rowinsky, et al.
Investigational New Drugs|January 1, 1997
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology GroupA N Leaf, D Neuberg, E L Schwartz, et al.
The International Journal of Biochemistry & Cell Biology|October 26, 1999
Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cellsR A Faust, G Niehans, M Gapany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1994
Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trialD R Vlock, C H Snyderman, J T Johnson, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Archives of Otolaryngology--Head & Neck Surgery|March 1, 1997
Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neckJ D McCaffery, M Gapany, R A Faust, et al.
The Journal of Infectious Diseases|August 19, 2000
Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-alpha: potential cause for mucoid otitis mediaJ Lin, A Haruta, H Kawano, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 17, 1998
Histopathology of human temporal bone after cis-platinum, radiation, or bothD L Hoistad, F G Ondrey, C Mutlu, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 1, 1994
Tobacco smoke and otitis media in the chinchilla modelP J Antonelli, K A Daly, S K Juhn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393A A Forastiere, T Leong, E Rowinsky, et al.
Investigational New Drugs|January 1, 1997
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology GroupA N Leaf, D Neuberg, E L Schwartz, et al.
The International Journal of Biochemistry & Cell Biology|October 26, 1999
Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cellsR A Faust, G Niehans, M Gapany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot studyD J Adelstein, L A Kalish, G L Adams, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1994
Phase Ib trial of the effect of peritumoral and intranodal injections of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trialD R Vlock, C H Snyderman, J T Johnson, et al.
Pageof 11